Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry.
Magerl M, Frank M, Lumry W, Bernstein J, Busse P, Craig T, Martinez-Saguer I, Riedl MA, Shapiro R, Edelman J, Williams-Herman D, Wood DN, Feuersenger H, Rojavin M; Berinert Registry Investigators. Magerl M, et al. Among authors: williams herman d. Ann Allergy Asthma Immunol. 2017 Jan;118(1):110-112. doi: 10.1016/j.anai.2016.10.006. Epub 2016 Nov 16. Ann Allergy Asthma Immunol. 2017. PMID: 27865714 Free article. No abstract available.
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
Riedl MA, Bygum A, Lumry W, Magerl M, Bernstein JA, Busse P, Craig T, Frank MM, Edelman J, Williams-Herman D, Feuersenger H, Rojavin M; Berinert Registry investigators. Riedl MA, et al. Among authors: williams herman d. J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):963-71. doi: 10.1016/j.jaip.2016.04.018. Epub 2016 Jun 8. J Allergy Clin Immunol Pract. 2016. PMID: 27286778 Free article.
Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.
Farkas H, Varga L, Moldovan D, Obtulowicz K, Shirov T, Machnig T, Feuersenger H, Edelman J, Williams-Herman D, Rojavin M. Farkas H, et al. Among authors: williams herman d. Ann Allergy Asthma Immunol. 2016 Nov;117(5):508-513. doi: 10.1016/j.anai.2016.08.025. Epub 2016 Oct 24. Ann Allergy Asthma Immunol. 2016. PMID: 27788880 Free article. Clinical Trial.
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients.
Busse P, Baker J, Martinez-Saguer I, Bernstein JA, Craig T, Magerl M, Riedl M, Shapiro R, Frank M, Lumry W, Rosch J, Edelman J, Williams-Herman D, Feuersenger H, Rojavin M; Berinert Registry Investigators. Busse P, et al. Among authors: williams herman d. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1142-1145. doi: 10.1016/j.jaip.2016.12.033. Epub 2017 Mar 9. J Allergy Clin Immunol Pract. 2017. PMID: 28286153 No abstract available.
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema.
Craig T, Shapiro R, Vegh A, Baker JW, Bernstein JA, Busse P, Magerl M, Martinez-Saguer I, Riedl MA, Lumry W, Williams-Herman D, Edelman J, Feuersenger H, Machnig T, Rojavin M. Craig T, et al. Among authors: williams herman d. Allergy Rhinol (Providence). 2017 Mar 1;8(1):13-19. doi: 10.2500/ar.2017.8.0192. Allergy Rhinol (Providence). 2017. PMID: 28381322 Free PMC article.
Efficacy of montelukast for treating perennial allergic rhinitis.
Philip G, Williams-Herman D, Patel P, Weinstein SF, Alon A, Gilles L, Tozzi CA, Dass SB, Reiss TF. Philip G, et al. Allergy Asthma Proc. 2007 May-Jun;28(3):296-304. doi: 10.2500/aap.2007.28.3000. Allergy Asthma Proc. 2007. PMID: 17619558 Clinical Trial.
42 results